Notch signaling is a highly conserved signal transduction pathway that regulates stem cell maintenance and differentiation in several organ systems. Upon activation, the Notch receptor is proteolytically processed, its intracellular domain (NICD) translocates into the nucleus and activates expression of target genes. Output, strength and duration of the signal are tightly regulated by post-translational modifications. Here we review the intracellular post-translational regulation of Notch that fine-tunes the outcome of the Notch response. We also describe how crosstalk with other conserved signaling pathways like the Wnt, Hedgehog, hypoxia and TGFβ/BMP pathways can affect Notch signaling output. This regulation can happen by regulation of ligand, receptor or transcription factor expression, regulation of protein stability of intracellular key components, usage of the same cofactors or coregulation of the same key target genes. Since carcinogenesis is often dependent on at least two of these pathways, a better understanding of their molecular crosstalk is pivotal.
Introduction
A tightly regulated spatio-temporal control of gene expression is required during embryogenesis and post-natal development, and in adult homeostasis and tissue repair. Cell-cell communication is used to properly coordinate and modulate gene expression programs by assembly and disassembly of coactivator and corepressor complexes.
A fairly low number of highly conserved signaling pathways have evolved that are re-used in different body locations and processes, and mediate such communication events. Among these, the Notch, Wnt, Hedgehog, hypoxia and TGFβ/BMP signaling pathways play critical roles in both embryonic and adult life. When these pathways still function, but are unbalanced, they often lead or contribute to disease development. The binding of ligands to their cognate receptors triggers an intracellular event that results in the accumulation/stabilization of intracellular signaling effectors and/or in their activation, mainly via post-translational modifications. Ultimately, the event culminates with the translocation of signaling effectors to the nucleus where they bind to enhancer regions mediating the (dis)assembly of coactivator complexes in a cell-type and locus-specific manner. Importantly, these signaling pathways do not operate in isolation, indeed they crosstalk to each other to ensure a more accurate and robust control of gene expression programs and resulting cellular responses Here, we review the current knowledge on post-translational regulation of the intracellular domain of Notch (NICD, also known as Notch-IC). We subsequently discuss how the Wnt, Hedgehog, hypoxia and TGFβ/BMP signaling pathways impact on Notch signaling, with a focus on the molecular mechanisms of action.
Introduction to Notch signaling
Almost a hundred years ago, Thomas Hunt Morgan discovered the first Notch mutant, a strain of fruit flies with "notches" at the margin of their wing blades. Notch signaling has subsequently been shown to be essential for embryonic and post-natal development and regulate diverse cellular processes, including stem cell maintenance, cell differentiation and cell death [1] [2] [3] . Activation of the Notch signaling pathway requires cell-cell contact between a Notch family ligand-presenting cell, which triggers then the cognate Notch receptor (Fig. 1) . Receptor-ligand interaction results in cleavage events catalyzed by extracellular ADAM metalloproteases [4, 5] and an intracellular γ-secretase-containing complex [6] releasing the NICD. Once released, the NICD translocates into the nucleus where it interacts with RBP-J (Recombination Signal Binding protein), also known as CSL (CBF-1, Suppressor of Hairless, Lag-1), building up a trimeric coactivator complex composed of RBP-J, MAML1 (Mastermind-like 1) and NICD itself [7] [8] [9] [10] , together with additional coactivators (Fig. 1) . The Notch coactivator complex facilitates histone acetylation leading to the expression of target genes. MAML1 interacts with the ankyrin repeats within NICD, stabilizes the interaction of the dimeric NICD/RBP-J complex [7] , and recruits the histone acetyltransferase p300 [11] required for acetylation of histone proteins and, as a consequence, opens-up the chromatin. MAML1 also regulates the activity of p300 by increasing its autoacetylation and hence its transcriptional activity [12] . However, at the same time p300 acetylates MAML1 thereby destabilizing the MAML1-p300 interaction [13] , suggesting a negative feedback loop that regulates the assembly and disassembly of the MAML1/p300 complex to terminate transcriptional responses to Notch. The MAML1-p300 dimeric complex regulates the stability of the Notch coactivator complex also via acetylation of the NICD itself, an event that counteracts the ubiquitin-dependent proteasomal degradation of the NICD [14] . In addition to RBP-J/NICD/ MAML1 and p300, the RNA helicase Ddx5 [15, 16] and the long noncoding RNA (lncRNA) steroid receptor coactivator (SRA) [15] were shown to be part of the coactivator complex and required for p300 recruitment at Notch-dependent enhancer sites.
Regulation of the NICD by post-translational modifications
Mutations that increase the half-life of NICD have been linked to leukemia [17] , illustrating how tightly the amplitude and duration of the Notch response need to be controlled for proper tissue homeostasis. The Notch response is tuned by post-translational modifications of the NICD ( Fig. 2A and Table 1 ) that regulate its half-life and hence the NICD-dependent transcriptional output.
Structurally the NICD is characterized by a RAM (RBP-J associated module) domain and ankyrin (ANK) repeats ( Fig. 2A) , which both are required for signal transduction. The RAM domain contains several nuclear localization signals (NLSs) and together with the ANK repeats it represents the binding module for RBP-J. At the C-terminus the NICD also contains a transactivation domain (TAD) followed by a [66] [67] [68] [69] 71, 74] , Smad proteins [132, 139, 140, 145, 146] and HIF-1α [112] . HIF-1α increases the activity of the γ-secretase complex (γSC) resulting in enhanced Notch signaling [114] . Double arrows indicate physical interaction. glutamine-rich OPA domain, and by a proline-, glutamic acid-, serineand threonine-rich (PEST) domain, that destabilizes the NICD itself [18] ( Fig. 2A) . Several mutations or truncations that impair the function of the C-terminal PEST domain have been reported in cancer [17, 19, 20] . Phosphorylation of the NICD-1 (see Table 1 ) is mediated by several kinases and among them the cyclinC/cyclin-dependent kinase 8 (CycC/CDK8) complex plays a key role [21] . The CycC/CDK8 complex targets serine residues located within the PEST domain of NICD-1 and supports NICD-1 ubiquitination by Fbw7/Sel10 and its subsequent degradation [21] [22] [23] [24] [25] [26] [27] . Mutations that impair the function of Fbw7/ Sel10 co-occur with Notch mutations in T-acute lymphoblastic leukemia (T-ALL) [25, 28] and recently it was shown that NICD-3 itself indirectly regulates the levels of Fbw7/Sel10 via miR-223 in T-ALL cell lines [29] . Additionally, the stability of NICD-1 is regulated via phosphorylation by unknown kinase(s) within its highly conserved sequence WSSSSP [30] , and additional serine residues are phosphorylated by Nemo-like kinase (NLK) [31] and see Table 1 ]. Phosphorylation of the NICD-1 is also mediated by the Down-syndrome-associated kinase DYRK1A [32] , glycogen synthase kinase 3β (GSK-3β) [33] , casein kinase II (CKII) [34] and atypical protein kinase Cζ (aPKCζ) [35] . Furthermore, phosphorylation does not exclusively occur on the NICD-1, but also on other Notch family members. For example, NICD-2 phosphorylation is mediated by unknown kinase(s) at a highly conserved serine (S2078) [36] . Additional serines and threonines within NICD-2 are again phosphorylated by GSK-3β [37] .
Acetylation is also an important modification of the NICD. Using liquid chromatography-tandem mass spectrometry analysis 14 different acetylation sites were identified within the murine NICD-1 [38] and see Table 1 ]. The acetyltransferases p300 and PCAF, but not Tip60 (also known as KAT5), acetylate NICD-1, and these events are dynamically regulated by the deacetylase Sirt1. However, it remains unclear which of the 14 lysines are acetylated by p300 and/or PCAF and which ones are deacetylated by Sirt1. Functionally, the acetylation of NICD-1 prevents its ubiquitination [14, 38] , supporting the hypothesis of a 'Notch code' where a specific modification of NICD has an impact on further post-translational modifications and finally on its turnover. It remains to be seen how the acetylation of the NICD-1 influences its ubiquitination; it might occur in three different modalities: 1) the acetyl mark might change the NICD-1 conformation, masking its ubiquitination site(s); 2) the acetyl-lysine might mask the docking site for enzymes of the ubiquitin pathway, preventing their binding; and 3) a combination of the two previous mechanisms.
Acetylation of the intracellular domain of Notch-3 has also been reported. In particular, NICD-3 is acetylated on lysines 1692 and 1731 by p300 (but not Tip60), and treatment with the histone deacetylase inhibitor Trichostain A (TSA) increases its acetylation [39] . Surprisingly, the effect of NICD-3 acetylation on protein stability is opposite to that observed for NICD-1 as exemplified by the observation that acetylation of NICD-3 increases its ubiquitination and, as a consequence, decreases its stability and transcriptional activity [39] . The acetylation/ ubiquitination crosstalk on NICD-3 protein is poorly characterized, but importantly treatment with TSA prevents T-ALL development in a Notch-3-dependent T-ALL mouse model, opening the road to the pharmacological use of HDAC inhibitors in human T-ALL treatment [39] .
Notch-1, Notch-2 and Notch-3 have been described to be hydroxylated by factor inhibiting HIF (FIH) at two highly conserved asparagine residues located within the ANKs of NICD [40] [41] [42] and see Table 1 ]. NICD hydroxylation seems to influence neither its interaction with RBP-J or with the NICD interactors SKIP (Ski-interacting protein) and Deltex. However, these conclusions are based only on the ANK repeats of Notch and not on the entire NICD, a condition that does not reflect the physiological context [40] . Thus, the function of NICD hydroxylation remains to be further investigated.
Interestingly, proline-isomerization of the Notch1 protein, mediated by the prolyl-isomerase Pin1, regulates proteolytic cleavage at the plasma membrane and transcriptional activity of the NICD-1 [43] . Pin1 mRNA is also upregulated by Notch activation, establishing a positive loop that amplifies Notch-1 dependent signaling [43] .
Five arginine methylation sites were identified within the TAD domain of Notch-1 using a HeavyMethyl SILAC approach [44] and see Table 1 ]. This methylation is regulated by the arginine methyltransferase CARM1 (also known as PRMT4), which has been linked to Notch transcriptional responses [45] . CARM1 localizes to the enhancer regions of the Notch target genes preTCRα, Gm266, Hes1 and CD25 and regulates also the turnover of NICD-1. Mutation of all five arginines to alanines (NICD-1 5RA) impairs the ubiquitination of NICD-1 and stabilizes the protein [44] . Surprisingly, the stabilization of the 5RA mutant does not result in a significant increase of its transcriptional activity compared to the control NICD-1 [44] . This result is in line with previous observations [23] and is explained by a mathematical model wherein the normal NICD-1 produces a short, strong transcriptional pulse, whereas the NICD-1 5RA mutant results in a weaker but prolonged response [44] .
Finally, NICD ubiquitination regulates its proteasomal-dependent turnover and as consequence has a strong impact on its transcriptional activity. In addition to Fbw7/Sel10 the E3 ubiquitin ligase Itch also causes ubiquitination and modulates turnover of the NICD-1 [46] [47] [48] [49] . Interestingly, the E3 ubiquitin ligase Mdm2 was shown to support protein degradation of NICD-4 [50] , whereas it potentiates the transcriptional activity of NICD-1 [51] , suggesting that Mdm2 plays opposing functions on the different Notch family members. The homo-dimerization of the NICD was shown to be a critical step to support transcription [52, 53] . In vivo, it is required for leukemogenesis and T-cell maturation but dispensable for T-cell specification [54] . Structural studies have identified lysine 1945, glutamic acid 1949 and arginine 1984 as key residues for the Notch dimerization [52] . One can hypothesize that the post-translational modification of these or flanking residues can affect the dimerization and thereby the duration of Notch-dependent transcriptional responses. Surprisingly however, the Notch dimerization is only required to induce a subset of Notch target genes like c-Myc, preTCRα and Nrarp, which contain two RBP-J binding sites oriented head-to-head and spaced by 16 bp in their enhancer regions [52] [53] [54] . Hes1 is a Notch target gene that can be induced in a Notchdimerization independent fashion: a dimerization-defective Notch mutant is still able to induce Hes1 expression, albeit to a lower extent when compared to the wild-type Notch [53, 54] . This result might be explained by the presence of both monomeric and dimeric Notch (RBP-Jbound) sites at the Hes1 locus. It further suggests the fascinating hypothesis that post-translational modifications of NICD might prevent its homo-dimerization while leaving the transcriptional regulation by monomeric NICD intact and hence affecting not only the duration, but also the strength of transcription.
Crosstalk between Notch and Wnt signal transduction pathways
The Wnt signaling pathway regulates a large variety of biological processes such as the self-renewal capacity of stem cells [55] , and T-cell development and differentiation [56] . In the absence of Wnt, the β-catenin destruction complex, composed of APC (adenomatous polyposis coli), Axin, GSK3β and casein kinase I (CKI), regulates the cytosolic concentration of β-catenin via phosphorylation of β-catenin and consequent proteasomal degradation. The binding of secreted Wnt ligands to the transmembrane receptor Frizzled that cooperates with the coreceptor LRP5/6, causes the recruitment of Dishevelled (Dvl) that supports the dissociation of the β-catenin destruction complex by sequestering Axin to the plasma membrane (Fig. 3A) . This leads to the cytosolic accumulation of β-catenin, which translocates ultimately into the nucleus, and dimerizes there with transcription factors TCF (T-cell factor)/LEF (lymphoid enhancer factor), leading to activation of target genes [57] and Fig. 3A] .
The β-catenin destruction complex plays a key role in the finetuning of the Wnt signaling pathway through regulation of the stability of β-catenin. Mutations that impair the activity of the β-catenin destruction complex have been linked to several types of cancer. For example, mutations in APC or AXIN have frequently been observed in colorectal cancer [58] [59] [60] . Such mutations compromise the activity of the β-catenin destruction complex and result in accumulation of β-catenin with consequent aberrant activation of the pathway. Not surprisingly, mutations in β-catenin that dysregulate the phosphorylation of the protein and hence degradation, are frequently observed in colorectal cancer too [61] .
The Notch and Wnt signal transduction pathways can regulate each other and hence affect their transcriptional output [62] . [63] . In mouse, the Wnt pathway was shown to regulate the expression of the Notch ligand Delta-like1 (Dll1), which itself is a Notch target gene [64] and Fig. 4 ]. Importantly, the Notch target gene Hes1, which encodes a strong basic helix-loop-helix (bHLH) transcriptional repressor, is also regulated by β-catenin-mediated Wnt signaling [65] [66] [67] and Fig. 4] . Furthermore, biochemical studies revealed that the direct interaction between β-catenin and Notch-1 (Fig. 2B) reduces the ubiquitination of Notch-1, which results in increased expression of Hes1 [68] . In another study the Notch/RBP-J/β-catenin interaction was described to occur at several target genes and to synergistically support angiogenesis [69] .
The serine/threonine kinase GSK3β, which mediates phosphorylation of β-catenin and boosts thereby its degradation, represents an important hub in Wnt and Notch signaling crosstalk (Fig. 4) . Remarkably, GSK3β phosphorylates serine and threonine residues of NICD-1, leading to its nuclear localization and increasing its stability and transcriptional activities [33, 70] . GSK3β was also reported to phosphorylate NICD-2 but, in contrast to NICD-1, the GSK3β-dependent NICD-2 phosphorylation results in decreasing its transcriptional activity [37] . Thus, phosphorylation of either NICD-1 or NICD-2 can potentially have different outcomes and this might also be cell-type specific.
Notch tethers β-catenin and hence negatively regulates the latter's stability [71] [72] [73] . Notch-1 loss-of-function leads to activation of β-catenin and increases the transcriptional activity of a β-cateninresponsive reporter construct, suggesting that Notch dampens β-catenin-mediated responses to Wnt [74] .
The non-canonical Wnt/Ca 2+ pathway cooperates also with Notch signaling. In the non-canonical Wnt/Ca 2+ pathway, the activation of the receptor Frizzled activates a signaling cascade that culminates with the release of Ca 2+ from the endoplasmic reticulum, which activates the calcium calmodulin-dependent protein kinase II (CaMKII) [75] . Activation of CamKII by Wnt5a, a representative ligand that activates the β-catenin-dependent and β-catenin-independent pathways, triggers the phosphorylation of the RBP-J-interacting corepressor SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) on serine 1407, resulting in increased promoter activity of a Notch-responsive reporter construct [76] . Conversely, there is also evidence that Notch synergizes with Wnt signaling during T-cell development: Notch upregulates the mRNA levels of the canonical Wnt-transcription factor TCF1 [77, 78] . Furthermore, the Wnt-receptor Frizzled is activated by Notch signaling in dendritic cells, stimulating their differentiation [79] . The Notch target gene Nrarp (Notch-regulated ankyrin repeat protein) not only acts as a negative feedback regulator of Notch, but also as a positive regulator of Wnt [80, 81] . Nrarp orchestrates its positive function on Wnt signaling via stabilization of the transcription factor LEF1, leading to increase in LEF1-dependent promoter activity [81, 82] .
Finally, it is important to note the biological importance of the Notch-Wnt crosstalk in carcinogenesis: Wnt signaling positively regulates the expression of Notch-2 in colorectal cancer cells [83] and induces the expression of the Notch ligand Jag1 in ovarian cancer [84] (Fig. 4) .
Wnt and Notch signaling often act synergistically. However, in another context, Wnt can also negatively regulate Notch activity. Dvl functionally integrates Wnt and Notch regulation. Overexpression of Dvl but not overexpression of β-catenin reduces the promoter activity of a Notch-responsive reporter construct in the presence of a Notch signal [85] . The inhibitory effect of Dvl is relevant in vivo as loss-offunction of Dvl results in a decrease of ciliated cell precursors, which is negatively regulated by Notch signaling. The inhibitory effect of Dvl is mediated via its physical interaction with RBP-J, thereby reducing the transcriptional activity of RBP-J [85] . Alternatively, or in addition, it has also been reported that Dvl interacts with Notch receptor regulating its endocytosis in Drosophila [86, 87] .
Crosstalk between Notch and Hedgehog signaling
The Hedgehog (Hh) signaling pathway is initiated by the binding of Hh family ligands to their receptors Patched (Ptch1/2), a 12-pass transmembrane protein. This event derepresses the 7-pass transmembrane protein Smoothened (Smo), which initiates additional steps to activate the transcription factor Gli (glioma-associated oncogene) (Fig. 3B) . Proper Hh signaling is crucial for correct embryogenesis, also of mammals. In post-natal life, the Hh pathway is spatially restricted and its proposed role is the induction of proliferation of adult stem cells, which are required for tissue maintenance and repair [88, 89] . Moreover, Hh signaling is particularly important for the development of tumorstroma [90, 91] .
Expression of Hes1 can be induced by the Hh signaling pathway in a Notch-independent manner in multi-potent mesodermal cells [92] and retinal explants [93] (Fig. 4) . This induction requires the activity of both Gli1 [94] and Gli2 [93, 95] , and binding of Gli2 to the Hes1 locus was revealed by ChIP [93] , suggesting a direct regulation of Hes1 by the Hh signaling pathway. On the other hand, another study has demonstrated that Hes1 represses Gli1 in glioblastoma-derived neurospheres via [64, 67, 83, 84] and ligands [64, 84] . Furthermore, GSK-3β potentiates Notch-dependent gene expression via phosphorylation of Notch-1 [33, 70] but can also reduce the transcriptional activity of Notch-2 [37] (not represented). The Hedgehog (Hh) signaling pathway induces activation of Hes1 Notch target gene [92] [93] [94] [95] and of Notch receptors [94, 95] and ligands [94, 97] . Hypoxia crosstalks with the Notch signaling pathway via induction of Notch ligands [109] [110] [111] [121] [122] [123] 125] and receptors [122] and common target genes like Hes1 [111, 112, 114, [121] [122] [123] 125, 127] . Furthermore, under normoxia FIH crosstalks with Notch via NICD hydroxylation [40] [41] [42] . Similar mechanisms are used by the BMP/TGFβ signaling pathway to crosstalk with Notch. For example it can induce expression of ligands [128, 130, 133, 134, 136, 142, 155] , receptors [155] or of Notch target genes like Hes1 [128, 129, [133] [134] [135] [136] [140] [141] [142] . For simplicity, ligands or receptors that are repressed within the network are omitted. Dotted lines indicate a post-translational-dependent crosstalk whereas red arrows indicate a gene induction-dependent crosstalk. Similar mechanisms can be used to control the expression of other Notch target genes such as Hey1, Hey2 and/or HeyL.
binding to the N-boxes located within the first intron of Gli1 [96] . It is still unclear whether Gli1 and Hes1 regulate each other's transcription in the same cell type, but if they do so, it is tempting to speculate that the cooperative feedforward and antagonistic feedback interactions lead to sharp and transient pulses of signaling of both pathways. In line with these observations the Notch ligand Jagged1 and Gli2 regulate each other's mRNA levels in a positive manner in ovarian cancer cell lines; surprisingly, the regulation of Gli2 by epistatic Jagged1 occurs in a Notch-independent manner [97] . Furthermore, activation of the Notch signaling pathway induces the expression of Sonic Hedgehog (SHh) in neural stem cells [98] , while induction of Gli1 results in upregulation of both Notch ligand Jag1 and Notch-1 receptor mRNAs in different regions of the brain [94] and Fig. 4 ]. Taken together, there is numerous evidence for crosstalk between the Hh and Notch pathways, with the majority of reports describing a positive interaction.
Recently, novel mechanistic insight into how Notch activity could increase Hh signaling effectiveness was provided: Notch regulates transport processes in and out of the primary cilium, a signaling center crucial for proper Hh pathway coordination [99] . Since Ptch1 and Smo localize to the cilium, Notch sets the overall cellular threshold for Hh responsiveness by impacting on the ciliary transport of Ptch1 and/or additional ciliary signaling molecules [100] . In this regard it is intriguing that Notch-3 and Presenilin2, a subunit of the γ-secretase complex, also localize to/around primary cilia, e.g. in keratinocytes [101, 102] .
Therapeutically, the Notch-Hh crosstalk seems to represent a sensitive node for targeted intervention. Combinatorial inhibition of Notch and Hh signaling reduces the viability of both CD133
+ glioma stem cells [103] , hormone-refractory prostate cancer cell lines [104] and T-ALL cell lines with Notch mutations [105] . In contrast, Notch signaling cooperates with miR-7 to silence Hh signaling, thereby promoting tumorigenesis in Drosophila [106] . However, it is currently unclear if this interaction loop is regulating tumorigenesis also in humans.
Crosstalk of Notch with hypoxia signaling
Compared to the Notch, Wnt, Hh and TGFβ/BMP signaling pathways, the hypoxia pathway does not require secreted or transmembrane proteins, instead it senses oxygen concentrations. Oxygen represents the key cofactor for both prolyl-hydroxylases (PHDs) and factor inhibiting HIF (FIH). Once active, FIH and PHDs hydroxylate the transcription factors hypoxia-inducible factor α (HIF-1α and HIF-2α) at asparagine and proline residues, respectively. While FIH-dependent hydroxylation of HIF-α proteins prevents their interaction with p300, the PHDdependent hydroxylation does target HIF-α for proteasomal degradation via von Hippel-Lindau (VHL)-dependent ubiquitination. Under hypoxia, both FIH and PHDs are inactive, resulting in stabilization of HIF-α proteins that dimerize with HIF-1β; this complex binds to hypoxia-responsive elements (HRE) and triggers transcription of target genes such as Vegf (vascular endothelial growth factor) that leads to stimulation of angiogenesis [107, 108] (Fig. 3C) .
One of the first evidences for crosstalk between Notch and hypoxia signaling emerged when it was shown that hypoxia leads to an upregulation of the Notch ligand Delta-4 (Dll4)-encoding gene in a HIF-1α-dependent manner [109, 110] and Fig. 4 ]. The underlying mechanism was revealed when NICDs were shown to be hydroxylated by FIH [40] [41] [42] . Upon hypoxia, FIH is no longer functional and the hydroxylation of NICD-1 is significantly reduced. Surprisingly, loss-of-function of FIH does not influence the transcriptional activity of NICD-1 in luciferase reporter assays [40] even though two independent studies showed that Notch target genes are induced under hypoxia and that this induction is dependent on Notch activity [111, 112] . In addition, the loss of FIH function leads to upregulation of the Hey1 Notch target gene in HUVECs [113] . Two additional reports reveal that the interplay of Notch and hypoxia has even additional layers of complexity: 1) nuclear HIF1α synergizes with NICD-1 to upregulate a subset of target genes for Notch and this occurs via a physical interaction between HIF1α and NICD-1 [112 and Fig. 2B]; 2) upon induction of the hypoxic response, cytoplasmic HIF-1α increases the activity of the γ-secretase complex, causing a strong increase in the release of NICD and finally in the expression of the target gene Hes1 [114] and Fig. 2B] .
The crosstalk between Notch signaling and the hypoxia response is particularly important as Notch signaling is critical in balancing sprouting angiogenesis [115] . Mice deficient for either Notch receptors or ligands show severe defects in vascular remodeling [116] [117] [118] and Notch signaling was described to induce the expression of Vegfr-1 gene (encoding VEGF receptor 1) [119] and to repress Vegfr-3 [120] .
The Notch-hypoxia crosstalk is relevant for epithelial-tomesenchymal transition (EMT) as it potentiates Notch signaling and increases invasion of breast cancer cells [121] , oral squamous cell carcinoma cell lines [122] and ovarian carcinoma cell lines [123] . Furthermore, the Notch-hypoxia crosstalk contributes to the progression of prostate cancer [124] , invasion of uveal melanoma [125] and maintenance of glioblastoma stem cells [126, 127] .
Crosstalk between Notch and TGFβ/BMP signaling
Members of the transforming growth factor type beta (TGFβ) family, including bone morphogenetic proteins (BMP), control a plethora of context-dependent cellular processes in embryogenesis and adult tissue homeostasis. Ligand-receptor interactions can trigger Smad-dependent and non-Smad signaling cascades. Here we will only focus on Smadmediated responses because crosstalk with the Notch pathway has been chiefly reported for this cascade. Liganded receptor complexes activate intracellular effector proteins, the receptor-regulated Smads. Smad1, Smad5 and Smad8 are phosphorylated in response to BMP signals, while Smad2 and Smad3 become phosphorylated in response to TGFβ/activin-like signals. Phosphorylation of these Smads leads to their interaction with the common mediator Smad4, and subsequent translocation of the complex to the nucleus (Fig. 3D ). The Smad transcriptional complexes then pair with other context-dependent transcription factors (and cofactors thereof) to regulate hundreds of genes, with often very distinct gene sets being regulated by the Smad1/5/8 versus Smad2/3 effectors. There is compelling evidence that the Notch and the Smad-pathways interact. Several examples will be discussed here.
BMP and TGFβ signaling can affect Notch ligand and receptor levels. For example, the activation of the TGFβ signaling pathway in mesenchymal stem cells results in upregulation of the Notch ligand encoding gene Jag1, which in turn activates the Notch pathway supporting differentiation of smooth muscle cells [128] and Fig. 4 ], while in fibroblasts the activation of TGFβ signaling results in repression of Notch-3, which supports smooth muscle cell differentiation as well [129] . These observations suggest that stem cells and fibroblasts adopt two different strategies to differentiate into smooth muscle cells. BMP signaling was shown to regulate expression of Jag1 directly in endothelial cells through binding of C-terminally phosphorylated Smad1/5 to GC-rich SMAD-binding elements in the Jag1 promoter [130] . Though Jag1 is known to activate the receptor Notch in many cells, Jag1 and Dll4 may exert profound opposite effects. For example, in endothelial cells their opposite effect can be explained by Jag1-mediated inhibition of Dll4-Notch signaling critical for sprouting angiogenesis [131] .
Notch and TGFβ/BMP signaling cooperatively regulate several Notch target genes, such as Hey1/2 and Cdh2 [132] [133] [134] , although activated Smad1 can also act in a Notch-independent manner to activate the Hey-1/2 promoters [130, [135] [136] [137] [138] . NICD and Smad4 cooperate in regulating Cdh2 encoding N-cadherin [139] . ChIP analysis supported that BMP-as well TGFβ-regulated Smads formed a complex with NICD and RBP-J, and that TGFβ/BMP enhanced the recruitment of the complex to the RBP-J binding site on the promoter to transactivate Cdh2 [139] .
The Notch target gene Hes1 represents another example of the Notch-TGFβ crosstalk (Fig. 4) ; Hes1 is induced by TGFβ [128, 129, 140, 141] and its proximal promoter is characterized by two conserved Smad-binding motifs [129] . Importantly, luciferase reporter assays revealed that the Hes1 promoter is responsive to Smad2, but not Smad3 in mouse fibroblasts [129] , even though the occupancy of Smad3 at the Hes1 promoter could be revealed by ChIP in human keratinocytes in another study [142] . This discrepancy likely reflects a context-dependent Smad usage to induce Hes1. BMP-Smads have not been demonstrated to regulate Hes1 directly, yet overexpression of the Smad1/5 acknowledged target genes encoding Inhibitor of differentiation proteins (IDs), promotes Hes1 expression in endothelial cells [133] . ID proteins are potent inhibitors of differentiation of progenitors of different cell types; they promote cell-cycle progression, delay cellular senescence, and facilitate migration [143] . These small polypeptides harbor a helix-loop-helix (HLH) motif that lacks DNA-binding capacity. They are known to mediate through dimerization with E-type basic HLH (bHLH) DNA-binding transcription factors and hence interfere with the bHLH-mediated gene regulation [143] . The Hes1 and Hey1 NICD effectors are potent transcriptional repressors that can also dimerize with Ids [144] . The ID-Hes1 heterodimer formation might explain how the negative autoregulation of Hes1 is counteracted by BMP-Smads [132, 133, 144] .
NICD-1 and NICD-4 were shown to interact with Smad3 [140, 145, 146] and Fig. 2B ]. Whereas the NICD-4/Smad3 interaction has a negative impact on TGFβ-dependent transcription [146] , the NICD-1/Smad3 interaction enhances both TGFβ-dependent and Notch-dependent transcription of downstream genes [140] , which again likely reflects contextual differences.
In the developing heart, Notch signaling initiates EMT in the endocardium of the atrioventricular canal (AVC), triggering valve formation; both BMP and TGFβ signaling act in concert with Notch to promote the transition of endothelium to mesenchyme and the mesenchymal invasiveness in this process [147] .
BMP/TGFβ signaling can also antagonize Notch signaling. Remarkably, Notch and BMP signaling seem to synergize and to antagonize each other often in the same cell type, which likely illustrates that the interplay between positive feedforward and negative feedback mechanisms is required to control transient, but robust signaling output. In endothelial cells Smad1/5 induces, in a Notch-independent manner, expression of the ID genes [143] ; these ID proteins contribute on their turn to sustain Hes1 expression by releasing the negative autoregulation of Hes1 accumulation [144] , so BMPs synergize with Notch signaling. However, upon increased expression of Hey2, the Hey2 bHLH protein competes with Hes1 for binding to IDs and targets the Hey2-ID complexes for proteasomal degradation. The consequently reduced availability of IDs impacts on Hes1 levels because of increased autorepression of Hes1 [132, 133] . This example illustrates that context and relative abundance of Hes1, ID and Hey-components can pivot BMP and Notch between synergy and antagonism [148] . A recent study in zebrafish showed that in contrast to the cooperative interactions between DLL4/Notch and BMP9/activin receptor-like kinase 1 (ALK1)/Smad1/5 in enhancing arterial Notch target gene expression in cultured endothelial cells and mice [132] [133] [134] [135] [136] , abrogation of Alk1 signaling failed to decrease expression of Notch targets, and they uncovered opposing roles of Notch and Alk1 in expression of the Notch target and arterial marker, Dll4 [137] . This reflects probably spatio-temporal context differences and illustrates that extrapolation of results obtained even in one cell type or vascular bed should be done with extreme care.
Very recently, Neuropilin 1 (NRP1) has been shown to link Notch and TGFβ/BMP signaling [149] . NRP1 is a transmembrane coreceptor for several unrelated ligands. NRP1 has been shown to function as a Notch effector and links Notch with TGFβ/Alk5 (the latter being the type I receptor involved in its signaling) and BMP9/Alk1 signaling to regulate endothelial competition for the tip position. This Notch effector is the most critical determinant of tip cell formation and function known to date.
Notch signaling also affects BMP/TGFβ ligand and receptor levels. The loss of Notch signaling in mouse embryos causes defects in endocardial EMT in the AVC, which is associated with reduced levels of TGFβ receptors in endocardium, and loss of TGFβ2 in adjacent AVC myocardium [150] . Conversely, Notch signaling represses expression of BMP2 via Hey proteins in the non-AVC myocardium [147] .
In different oncogenic settings impaired TGFβ signaling has been correlated with disturbed Notch signaling. Dysfunctional TGFβ signaling in esophageal adenocarcinoma is associated with increased Notch signaling [151, 145] , whereas a positive functional cooperation between Notch and TGFβ was observed in clear cell renal cell carcinoma [152] and in lung carcinoma [153] , suggesting the Notch-TGFβ crosstalk as an important additional mechanism in carcinogenesis. Finally, the Notch-TGFβ crosstalk is relevant in kidney diseases [154] and during TGFβ-induced EMT [142, 155] .
It must be also considered that the Notch-TGFβ/BMP crosstalk is not exclusive to Notch-expressing cells, the so-called signal-receiving cells. In fact it might occur also in cells that express Notch ligands, the so-called signal-sending cells. In particular, it was shown that the intracellular domain of the Notch ligand Delta supports TGFβ-dependent transcription in luciferase reporter assays [156] .
Crosstalk between Notch and FGF signaling
Binding of FGF to the FGF receptor (FGFR) leads to receptor dimerization and activating phosphorylation resulting in changes in gene expression. Crosstalk between Notch and FGF signaling is critical during somitogenesis, a process required for the correct development of the body plan [157, 158] . Somitogenesis is accompanied by a rhythmic expression of genes controlled by the Notch, Wnt and/or FGF signaling pathways and feedback loops and crosstalk among these pathways are critical to control the rhythmic gene expression and as consequence somites formation [159] . The rhythmic expression of Hes1 was shown to be controlled by the FGF signaling pathway in mouse C3H 10 T1/2 cells and to correlate with the phosphorylation of ERK (extracellular signal-regulated kinase), a kinase downstream of the FGF signaling pathway [160] . In addition, the oscillating expression of the FGF inhibitor Sprouty4, in mouse presomitic mesoderm (PSM), is synchronized with the expression of the Notch target lunatic fringe (Lfng) and its rhythmical expression is dependent on the activity of the Notch target gene Hes7 [161] . Hes7 encodes for a repressor of transcription and surprisingly its repressive activity is not required to regulate the basal expression of Sprouty4 but to regulate its FGF-dependent induction [161] . Another example of crosstalk between Notch and FGF was described during asexual reproduction of the polyp Hydra vulgaris. In this context, Notch signaling is required to restrict the expression zone of kringelchen, the homolog of FGFR, to the boundary between parent and bud [162] . Inhibition of Notch signaling leads to a diffuse expression pattern of kringelchen associated with failure in foot formation and not completed detachment of the bud from the parent [162] .
Notch is known to crosstalk with even more signaling pathways, which have been extensively reviewed by others [163, 164] .
Outlook
The Notch signaling pathway is remarkably simple with just the trimmed receptor that exerts its function in the nucleus without intervention of classical second messengers. Yet, this highly conserved pathway integrates several additional inputs from other signaling pathways. One such key regulatory node is the post-translational modification of NICD. We reviewed several examples of such crossregulation: pathways can regulate each other by physical interaction (e.g. interaction between NICD and Smads), upregulation of ligands or receptors (e.g. Wnt regulating Notch ligand levels), common usage of regulators (e.g. hydroxylase FIH for hypoxia and Notch), coregulation of shared target genes (e.g. Hes1 regulation by Notch, Wnt, Hh and BMP/TGFβ). Identification of the key regulatory nodes between pathways will be an important base to design more specific inhibitors of a particular pathway avoiding cross-regulatory side-effects or to use combinatorial treatments. In addition, this knowledge is also forming the base for systems-biology type approaches to predict possible outcomes of receptor stimulation in a quantitative manner. In addition, precise biophysical measurements in the dynamic switch-on and switch-off systems should be used to identify the key regulatory mechanisms.
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